69 related articles for article (PubMed ID: 3189813)
1. Concurrent separation of catecholamines, dihydroxyphenylglycol, vasoactive intestinal peptide, and neuropeptide Y in superfusate and tissue extract.
Hunter LW; Rorie DK; Yaksh TL; Tyce GM
Anal Biochem; 1988 Sep; 173(2):340-52. PubMed ID: 3189813
[TBL] [Abstract][Full Text] [Related]
2. Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery.
Rorie DK; Hunter LW; Lunn JJ
Anesthesiology; 1990 Oct; 73(4):722-30. PubMed ID: 2221441
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y and 3,4-dihydroxyphenylglycol effluxes from artery are oxygen sensitive.
Rorie DK; Hunter LW; Tyce GM
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1371-8. PubMed ID: 1951723
[TBL] [Abstract][Full Text] [Related]
4. Extraction and radioimmunoassay quantitation of neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) from human dental pulp tissue.
El-Karim I; Lundy FT; Linden GJ; Lamey PJ
Arch Oral Biol; 2003 Mar; 48(3):249-54. PubMed ID: 12648563
[TBL] [Abstract][Full Text] [Related]
5. Dihydroxyphenylglycol as an index of neuronal uptake in dog saphenous vein.
Rorie DK; Hunter LW; Tyce GM
Am J Physiol; 1989 Dec; 257(6 Pt 2):H1945-51. PubMed ID: 2603979
[TBL] [Abstract][Full Text] [Related]
6. Dihydroxyphenylalanine and dopamine are released from portal vein together with noradrenaline and dihydroxyphenylglycol during nerve stimulation.
Hunter LW; Rorie DK; Tyce GM
J Neurochem; 1992 Sep; 59(3):972-82. PubMed ID: 1494920
[TBL] [Abstract][Full Text] [Related]
7. Determination of norepinephrine and its metabolites released from rat vas deferens using high-performance liquid chromatography with electrochemical detection.
Oishi R; Mishima S; Kuriyama H
Life Sci; 1983 Feb; 32(9):933-40. PubMed ID: 6827923
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of free and total catecholamines and two deaminated metabolites in man--rapid deconjugation by heat in acid.
Vlachakis ND; Kogosov E; Yoneda S; Alexander N; Maronde RF
Clin Chim Acta; 1984 Feb; 137(2):199-209. PubMed ID: 6705233
[TBL] [Abstract][Full Text] [Related]
9. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary.
Byrne JM; Jones PM; Hill SF; Bennet WM; Ghatei MA; Bloom SR
J Clin Endocrinol Metab; 1992 Oct; 75(4):983-7. PubMed ID: 1383256
[TBL] [Abstract][Full Text] [Related]
10. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal polypeptide and neuropeptide-Y, as possible mediators in laryngeal oedema. An immunofluorescence study.
Basterra J; Dilly PN; Perez M; Chumbley CC
Acta Otorhinolaryngol Belg; 1989; 43(2):99-104. PubMed ID: 2690564
[TBL] [Abstract][Full Text] [Related]
12. Determination of catecholamines and related compounds in mouse urine using column-switching HPLC.
Kanamori T; Funatsu T; Tsunoda M
Analyst; 2016 Apr; 141(8):2568-73. PubMed ID: 27029966
[TBL] [Abstract][Full Text] [Related]
13. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans.
Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR
Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of rat vasoactive intestinal peptide.
Dimaline R; Reeve JR; Shively JE; Hawke D
Peptides; 1984; 5(2):183-7. PubMed ID: 6473151
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
Wang JY; Yaksh TL; Go VL
Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase.
Leblanc GG; Trimmer BA; Landis SC
Proc Natl Acad Sci U S A; 1987 May; 84(10):3511-5. PubMed ID: 3554241
[TBL] [Abstract][Full Text] [Related]
17. Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.
Halbrügge T; Gerhardt T; Ludwig J; Heidbreder E; Graefe KH
Life Sci; 1988; 43(1):19-26. PubMed ID: 3386411
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y radio-immunoassay: characterization and application.
Allen R; Boublik J; Hauger RL; Scott N; Rivier J; Brown MR
Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):825-33. PubMed ID: 1797447
[TBL] [Abstract][Full Text] [Related]
19. Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells.
Goetzl EJ; Sreedharan SP; Turck CW
J Biol Chem; 1988 Jul; 263(19):9083-6. PubMed ID: 3379062
[TBL] [Abstract][Full Text] [Related]
20. Adenohypophyseal vasoactive intestinal peptide and neuropeptide Y responses to hypothyroidism are abolished after anterolateral deafferentation of the hypothalamus.
Michalkiewicz M; Suzuki M
Neuroendocrinology; 1994 Jan; 59(1):85-91. PubMed ID: 8145898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
